AQP4 and myeloid sarcoma: When specifically differentiating AQP4-IgG-seronegative NMOSD from MS, deoxycholic acid (DCA) demonstrated strong discriminative potential (AUC 0.965), with internally consistent performance across resampling- and cross-validation-based robustness analyses.